FDA approves Pfizer-BioNTech COVID-19 Vaccine
The U.S. Food and Drug Administration fully approved Pfizer-BioNTech, the first COVID-19 vaccine for use in those age 16 and older.
On Monday, the U.S. Food and Drug Administration fully approved the first COVID-19 vaccine for use in those age 16 and older. USA Health has been distributing the vaccine, known as the Pfizer-BioNTech COVID-19 vaccine, under an emergency use authorization since Dec. 15, 2020.
So far, USA Health has administered more than 86,600 doses of the vaccine, said Natalie Fox, DNP, assistant administrator and chief nursing officer for USA Health Physicians Group.
“We’re hopeful this will give people more confidence that the vaccine is safe and effective,” Fox said. “If you still have questions, talk to your healthcare provider.”
The vaccine continues to be available under emergency use authorization for those age 12 through 15 and for the administration of a third dose in certain immunocompromised individuals.
Where to get the COVID vaccine
- Children’s & Women’s Hospital
Friday clinics are planned at Children’s & Women’s Hospital through August. The final clinic in this series will be from 7 a.m. to 9 a.m. on Aug. 27 in the boardroom on the first floor.
- Strada Patient Care Center
On weekdays, USA Health offers no-appointment-needed COVID-19 vaccine injections at the Strada Patient Care Center from 8 a.m. to 4 p.m. where anyone age 12 or older can receive the Pfizer-BioNTech vaccine.
- Mobile Civic Center Arena
Drive-through COVID-19 vaccinations are given on weekdays at the Mobile Civic Center Arena beginning at 7 a.m. To self-schedule an appointment, visit usahealthvaccines.com.
